Diamond Sponsor

Novartis is a leading, global healthcare company headquartered in Basel, Switzerland. Founded in 1996 through the merger of Ciba-Geigy and Sandoz, Novartis has a heritage of innovation that spans more than 250 years.
Our purpose is: “Reimagine medicine to improve and extend people’s lives.” We are committed to delivering high-value medicines to address serious disease burdens, underpinned by technology leadership in research & development, and broad access-approaches.
Novartis’ global footprint spans over 118 countries with more than 78,000 employees and their medicines reach nearly 300 million patients worldwide.
With a focus on core therapeutic areas including oncology, immunology, cardiovascular disease and advanced platform technologies (such as gene and cell therapies), Novartis remains at the forefront of healthcare innovation.
Gold Sponsor

Modawina Medical Company (MMC) is a leading healthcare solutions provider based in the UAE, established in 2010. As a trusted regional partner to top international manufacturers, MMC delivers an extensive portfolio of advanced medical-equipment and technology solutions across radiology, nuclear medicine, surgical instruments, medical oncology, laboratory diagnostics, physiotherapy and rehabilitation.
With over 20 years of collective experience in the GCC and a client base covering more than 50 healthcare facilities, MMC is committed to elevating patient care through innovative products, reliable service and customer-first support. Their recent strategic partnership with SHINE Technologies for distribution of the non-carrier-added lutetium-177 isotope in the UAE further underscores their commitment to cutting-edge nuclear medicine and targeted cancer therapies.
We are proud to welcome Modawina Medical Company as a sponsor of the PET/CT Imaging Workshop at Cleveland Clinic Abu Dhabi and appreciate their support in advancing imaging excellence and innovation in healthcare.

Established in 1989, Zahrawi Group is a pioneer Medical Devices and Life Science Distributor in the Gulf region, with a presence in UAE, KSA, Qatar, Oman, and Bahrain. Zahrawi Group is specialized in Surgical, Medical, Nuclear Medicine, Diagnostic, and Analytical Lab solutions, and was founded with a vision to be the leading and most trusted partner in the GCC.
Zahrawi Group is committed to improving people’s lives by introducing innovative Healthcare products, Smart solutions, and Outstanding services.
Silver Sponsor

Bayer Radiology is a global leader in diagnostic imaging, providing innovative solutions that empower healthcare professionals to deliver accurate diagnoses and improve patient outcomes. As part of Bayer Pharmaceuticals, the Radiology division focuses on developing and delivering contrast media, medical devices, and advanced digital health solutions for radiology practices worldwide.
Bayer offers a comprehensive portfolio of gadolinium-based and iodine-based contrast agents for MRI, CT, and angiography.
Key products include:
Gadovist®: A high-concentration macrocyclic gadolinium-based contrast agent for MRI.
Ultravist®: A non-ionic contrast medium for CT and X-ray imaging.
Primovist®: A liver-specific MRI contrast agent.
MEDRAD® Injection Systems
Bayer provides state-of-the-art injection systems designed to ensure precision and safety during contrast administration. Bayer is at the forefront of integrating AI and digital technologies into radiology workflows through platforms like:
Calantic™ Digital Solutions: AI-powered tools for enhanced radiological decision-making.
Workflow and data management systems to streamline imaging and reporting.
Research & Development:
Bayer invests heavily in R&D, focusing on improving imaging accuracy and developing next-generation contrast agents. Emphasis on AI, precision imaging, and patient-centric innovation.
Commitment to Sustainability:
Bayer is committed to environmental sustainability through initiatives to reduce the environmental impact of contrast media waste and promote safer disposal practices. Focused on creating sustainable solutions for healthcare that align with Bayer’s 2030 sustainability goals.
Key Differentiators:
Innovation-Driven: Bayer leverages cutting-edge technologies, such as AI and machine learning, to enhance diagnostic accuracy.
Patient Safety: Known for high-quality contrast agents like Gadovist, designed with excellent safety profiles and superior diagnostic performance.
Global Expertise: Bayer combines global expertise with localized support to meet diverse healthcare needs.
Collaboration with Radiologists: Bayer partners with radiologists to optimize imaging protocols and enhance diagnostic workflows.
Mission Statement: To advance medical imaging through innovation, precision, and partnership, enabling healthcare professionals to deliver better outcomes for patients worldwide.

Cyclomedical International is a distinguished provider of comprehensive nuclear-medicine solutions and PET facility services with a global footprint. Established in the United States, the company has extended its expertise into the Gulf region—including the UAE, Qatar, and Oman—managing and consulting on cyclotron production, site planning, regulatory compliance, and facility operations
Their mission: to integrate business, technical and regulatory functions seamlessly so that lifesaving imaging technology can improve patient outcomes. With decades of experience operating radiopharmaceutical production sites and serving PET imaging clinics, Cyclomedical stands out as a trusted partner when it comes to achieving high-standards in safety, performance and efficiency.